Target intelligence / Profile preview

Cerebral motor cortex (MC)

Target
MC
Molecular classification
Other
01

Overview

The cerebral motor cortex is a specialized region of the frontal lobe essential for the planning, control, and execution of voluntary movements. It is anatomically divided into the primary motor cortex (M1), the premotor cortex, and the supplementary motor area, which collectively integrate sensory and cognitive inputs to generate motor outputs (StatPearls, 2023). Although it is an anatomical structure rather than a discrete molecular target, it serves as a primary site for therapeutic interventions targeting motor disorders through the modulation of its underlying neurotransmitter systems, such as glutamate and GABA (NIH, 2022). Degeneration of upper motor neurons within this region is a defining characteristic of amyotrophic lateral sclerosis (ALS), while localized damage from stroke often results in significant motor deficits or paralysis (NINDS, 2023). Pharmacological treatments often aim to stabilize cortical excitability or compensate for lost dopaminergic signaling in related circuits, as seen in Parkinson's disease management. Additionally, the motor cortex is a frequent target for non-invasive neuromodulation techniques like Transcranial Magnetic Stimulation (TMS) to treat depression or facilitate stroke rehabilitation (PubMed, 2021).

Other names
Motor cortexPrimary motor cortexM1Brodmann area 4Precentral gyrus
02

Mechanism of action

Pharmacological agents typically modulate synaptic transmission (glutamatergic or GABAergic) or ion channel activity within the neuronal circuits of the motor cortex rather than binding to the region as a single molecular entity.

03

Biological functions

Motor controlVoluntary movement executionMotor planningCoordinationOther
04

Disease associations

Neurodegenerative diseaseAmyotrophic lateral sclerosisStrokeCerebral palsyParkinson's diseaseEpilepsyOther
05

Safety considerations

Risk of motor impairmentSeizure inductionParalysisLoss of fine motor control
06

Interacting drugs

Riluzole

4 more in the full profile.

07

Biomarkers

Motor evoked potentials (MEP)fMRI BOLD signalCortical thicknessFractional anisotropy (DTI)

Beyond the preview

Go deeper on Cerebral motor cortex (MC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cerebral motor cortex (MC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call